Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.

Saved in:
Bibliographic Details
Title: Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.
Authors: Hernandez LD; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Racine F; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Xiao L; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., DiNunzio E; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Hairston N; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Sheth PR; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Murgolo NJ; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Therien AG; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA alex_therien@merck.com.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Feb; Vol. 59 (2), pp. 1052-60. Date of Electronic Publication: 2014 Dec 01.
Publication Type: Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25451052
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hernandez+LD%22">Hernandez LD</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Racine+F%22">Racine F</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Xiao+L%22">Xiao L</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22DiNunzio+E%22">DiNunzio E</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Hairston+N%22">Hairston N</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Sheth+PR%22">Sheth PR</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Murgolo+NJ%22">Murgolo NJ</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Therien+AG%22">Therien AG</searchLink>; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA alex_therien@merck.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2015 Feb; Vol. 59 (2), pp. 1052-60. <i>Date of Electronic Publication: </i>2014 Dec 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25451052
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1128/AAC.04433-14
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1052
    Titles:
      – TitleFull: Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hernandez LD
      – PersonEntity:
          Name:
            NameFull: Racine F
      – PersonEntity:
          Name:
            NameFull: Xiao L
      – PersonEntity:
          Name:
            NameFull: DiNunzio E
      – PersonEntity:
          Name:
            NameFull: Hairston N
      – PersonEntity:
          Name:
            NameFull: Sheth PR
      – PersonEntity:
          Name:
            NameFull: Murgolo NJ
      – PersonEntity:
          Name:
            NameFull: Therien AG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2015 Feb
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1098-6596
          Numbering:
            – Type: volume
              Value: 59
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Antimicrobial agents and chemotherapy
              Type: main
ResultId 1